Yale University

Transmission risk behaviour at enrolment in participants in the INSIGHT Strategic Timing of AntiRetroviral Treatment (START) trial.

TitleTransmission risk behaviour at enrolment in participants in the INSIGHT Strategic Timing of AntiRetroviral Treatment (START) trial.
Publication TypeJournal Article
Year of Publication2015
AuthorsRodger, Aj, Fc Lampe, Ae Grulich, M. Fisher, G. Friedland, N. Phanuphak, Jr Bogner, Lc Pereira, C. Rietmeijer, W. Burman, and An Phillips
Corporate AuthorsInternational Network for Strategic Initiatives in Global HIV Trials(INSIGHT) START Study Group
JournalHIV medicine
Volume16 Suppl S1
Pagination64-76
Date Published2015 Apr
ISSN1468-1293
AbstractA proportion of HIV-positive people have condomless sex. Antiretroviral treatment (ART) reduces infectiousness, but a substantial proportion of HIV-diagnosed people are not yet on ART. We describe baseline self-reported risk behaviours in ART-naïve Strategic Timing of AntiRetroviral Treatment (START) trial participants.
DOI10.1111/hiv.12235
Alternate JournalHIV Med.

External Links